11
Participants
Start Date
February 28, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Apo-Oxycodone CR®
a single 40mg oral dose of the controlled release oxycodone formulation Apo-Oxycodone CR®
OxyNEO®
a single 40mg oral dose of the controlled release oxycodone formulation OxyNEO®
Placebo
a single oral dose of placebo prepared using gelatin capsules and lactose filler with identical looking study capsules as the oxycodone products
Centre for Addiction and Mental Health, Toronto
University of Toronto
OTHER
Centre for Addiction and Mental Health
OTHER